Sun pharma is the biggest contributor in the Indian Pharma Index. So far, it has acted like a tired lion however, it seems the lion is ready to claim the kingship all over again.
Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point.
It completed its corrective wave (2) at 450 levels around September. It is all set to touch 630, 750 & 800 levels.
800 would be a crucial level to watch and any correction from those levels will be another buying opportunity.
Sun pharma has broken its 3-year downward trendline. RSI has already passed its complexion point.
It completed its corrective wave (2) at 450 levels around September. It is all set to touch 630, 750 & 800 levels.
800 would be a crucial level to watch and any correction from those levels will be another buying opportunity.
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak bertujuan, dan tidak membentuk, nasihat atau cadangan kewangan, pelaburan, dagangan atau jenis lain yang diberikan atau disahkan oleh TradingView. Baca lebih dalam Terma Penggunaan.